Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Dermatology Dermatology for November/December 2020 Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases, More severe AD correlates with worse sleep health and attention problems in children, Shortcomings identified in study of acne videos on TikTok, Study results support screening rosacea patients for cardiometabolic disease, More must reads Dermatology for September/October 2020 No lab monitoring needed in adolescents on dupilumab, Baricitinib reduces adult atopic dermatitis severity in phase 3 study, Study highlights differences between White and Latino patients with psoriasis, Shingrix effective in older adults with preexisting immune-mediated disorders, Review finds evidence for beta-blockers for some rosacea symptoms, More must readsDermatology for July/August 2020 Large study finds no link between TCI use, skin cancer in patients with AD, Beyond PASI 100: striving for molecular clearance, Study highlights potential advantages of tape strips over biopsy, Cohort study finds a twofold greater psoriasis risk linked to a PCOS diagnosis, Biologics may delay psoriatic arthritis, study finds, More must readsDermatology for May/June 2020 Eczema may increase lymphoma risk, cohort studies suggest, Pilot study shows apremilast effective for severe recurrent canker sores, Increased hypothyroidism risk seen in young men with HS, More phase 3 data reported for abrocitinib for atopic dermatitis, Vulvar melanoma is increasing in older women, More must readsDermatology for March/April 2020 Financial incentives affect the adoption of biosimilars, Most e-consults not followed by specialist visit, Dupilumab hits the mark for severe AD in younger children, Low-income DC communities have restricted access to iPLEDGE pharmacies, Antifungal drug appears safe for pregnancy, More must readsPages1 2 3 4 5 last »
